2600080
Study for the treatment of multiple sclerosis
18 - 55
- Male
- Female
> 14 days
Healthy
1
10300
Are you
- a healthy male or female
- between 18 and 55 years (inclusive)
- with a BMI between 18.5 and 32.0 kg/m² (inclusive)
- with a minimum weight of 50.0 kg
- who does not smoke or quit smoking at least 12 months prior to the screening visit (including nicotine-containing products)
- and does not use daily medication
What does this trial involve?
In study 2600080, SGS CPU investigates the treatment of multiple scleroris.
During +/- 9 weeks you will have the following appointments:
- a screening visit
- a morning return visit
- a stay of 31 days (30 overnight stays)
- an end of trial visit
Take part in this trial and
- contribute to the medicine of tomorrow
- a compensation will be provided
This study was approved by the competent Belgian health authorities and an independent ethics committee.
View information leaflet group B
